|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| G01N 33/567 | (2006.01) | ||
| C07H 21/04 | (2006.01) | ||
| C12P 21/06 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2452694 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11190796.0 |
| Date of filing the European patent application | 2006-06-30 | |
| (97) | Date of publication of the European application | 2012-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation | 2019-02-25 |
| (30) | Number | Date | Country code |
| 695831 P | 2005-06-30 | US |
| (72) |
Benson, Jacqueline, US
Cunningham, Mark, US
Duchala, Cynthia, US
Giles-Komar, Jill M., US
Luo, Jinquan, US
Rycyzyn,, Michael A., US
Sweet, Raymond, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-IL-23 antikūnai, kompozicijos, būdai ir panaudojimai |
| Anti-IL-23 antibodies, compositions, methods and uses |
| Payment date | Validity (years) | Amount | |
| 2023-06-19 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-06-30 |